FDA allows Veyonda® Pre-IND Submission for COVID-19
19 May 2020 Noxopharm (ASX:NOX) today announces that on advice from the U.S. Food and Drug Administration (FDA), the Company has lodged a pre-Investigational New Drug (pre-IND) submission for a clinical trial of Veyonda® in patients with SARS-CoV-2…
Four new projects announced for National Drug Discovery Centre
19 May 2020 Four research projects have been awarded generous Australian Government subsidies to fast-track their discoveries into new medicines using the National Drug Discovery Centre (NDDC) at The Walter and Eliza Hall Institute. The centre provides researchers…
Bosch puts fully automated mask-production lines into operation
15 May 2020 In the fight against coronavirus, Bosch has now turned its hand to the fully automated production of face masks. Dr. Volkmar Denner, chairman of the board of management of Robert Bosch GmbH, today launched the…
Case Study: Accelerating drug discovery at the Melbourne Biomedical Precinct
14 May 2020 33% of Australia’s 2017-2018 drug discovery efforts occurred within the Melbourne Biomedical Precinct (the Precinct) and continues to grow. The Precinct consistently attracts 23% of National Health and Medical Research Council (NHMRC) funding annually, more…
Public information key to combatting rising ‘superbug’ threat
14 May 2020 With predictions that drug-resistant ‘superbugs’ could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics. The rise of superbugs, which…
Mucus breakthrough could help patients breathe easy
14 May 2020 A discovery about how mucus thickness is regulated could help to improve airway-clearing treatment options for people with chronic respiratory conditions such as asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD). New insights into…
MTPConnect – 2020 Sector Competitiveness Plan
14 May 2020 In November of 2015, MTPConnect was established as an independent, not-for-profit organisation to drive connectivity, innovation, productivity and competitiveness in Australia’s medical technology, biotechnology and pharmaceuticals sector. In 2016, MTPConnect published a foundation plan for…
Blood test a potential new tool for controlling infections
12 May 2020 Researchers at the Walter and Eliza Hall Institute have published a new technique which could provide vital information about a community’s immunity to infectious diseases – including malaria and COVID-19. The diagnostic test analyses a…
Healthcare efficiency: AI technology to reduce hospital readmissions
11 May 2020 Monash University researchers are using Artificial Intelligence (AI) to better understand the cause of hospital readmissions, in turn improving health outcomes and reducing the financial burden on the health system. In the biggest study of…
Australian Medtech Startup is Using AI to Help Newborns in Intensive Care
6 May 2020 This article has been shared from Hive Life and is written by Stephanie H. Read the full original article here. Umbilical venous catheterisation is an emergency procedure performed on premature and critically ill newborns who…
CE mark for Trajan’s hemaPEN® blood microsampling device, now available for diagnostic use across EU and UK
7 May 2020 Trajan Scientific and Medical (Trajan) has declared hemaPEN® compliance with EU IVD Directive 98/79/EC, and its release for in vitro diagnostic use in the EU and UK. This follows the hemaPEN’s recent addition to the…
Certara & DMTC Collaborate to Study Using Chloroquine in Healthcare Workers at Risk for COVID-19
7 May 2020 Certara®, the global leader in model-informed drug development, and DMTC (formerly the Defence Materials Technology Centre) Ltd, which works to enhance Australia’s defense and medical countermeasure capabilities, have entered into a…
